Sign in to view content

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K. Maturi, MD

Video
Published 2021

Related

E27- DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
LEAVO Trial - Comparison of Anti-VEGF drugs for Macular Edema Secondary to CRVO- Dr. Philip Hykin
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Potential Safety Concerns of Bevacizumab
Robert L. Avery, MD
Updates from the Field
2017

Category: Pharmacology

See more